The role of the small intestine in modulating metabolism and inflammation in atherosclerosis and cancer. 
To discuss recent findings on the importance of the small intestine in modulating metabolism and inflammation in atherosclerosis and cancer.  Integrin β7 natural gut intraepithelial T cells modulated metabolism and accelerated atherosclerosis in mice.  Reducing the generation of lysophospholipids in the small intestine mimicked bariatric surgery and improved diabetes.  Enterocyte-specific knockdown of stearoyl-CoA desaturase-1 significantly improved dyslipidemia in LDL receptor null (Ldlr) mice fed a Western diet.  Adding a concentrate of tomatoes transgenic for the apolipoprotein A-I mimetic peptide 6F to the chow of wild-type mice altered lipid metabolism in the small intestine, preserved Notch signaling and reduced tumor burden in mouse models.  The phospholipid-remodeling enzyme Lpcat3 regulated intestinal stem cells and progenitor cells by stimulating cholesterol biosynthesis; increasing cholesterol in the diet or through genetic manipulation promoted tumorigenesis in Apc mice.  The small intestine is important for regulating metabolism and inflammation in animal models of both atherosclerosis and cancer.